Jan 27 2010
Acacia Research Corporation (Nasdaq:ACTG) announced today that a
subsidiary has acquired patents for medical devices using shape memory
alloys.
“As
our licensing success grows, more patent owners are selecting us as
their partner for the licensing of their patented technologies”
"Acacia continues to grow its base of future revenues by adding new
patent portfolios,” commented Paul Ryan, Acacia Chairman and CEO. “As
our licensing success grows, more patent owners are selecting us as
their partner for the licensing of their patented technologies,”
concluded Mr. Ryan.
The patented technology generally relates to using shape memory alloys
such as Nitinol to fabricate medical devices that utilize the memory
effect and/or superelasticity of the alloy. The technology can be used
to improve cardiovascular and endoscopic procedures such as embolic
protection (inferior vena cava filters, carotid filters, etc.) and
kidney stone retrieval.
SOURCE Acacia Research Corporation
New research explores how antimicrobial exposure affects Parkinson’s disease risk